The Chancellor’s Spending Review, delivered on 11 June, outlines major investment priorities for 2026–2030 with big implications for life sciences. From UKRI to the NHS, find out what it means for the sector and what to expect from the upcoming Industrial Strategy. Watch this webinar and listen in on BIA experts as they unpack the headlines.